YTE reported $660.32M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Agenus AGEN:US $ 168.75M 30.38M
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Amgen AMGN:US $ 14585M 1716M
Biogen BIIB:US $ 3347.2M 181.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Cerulean Pharma CERU:US $ 6M 0.1M
Chemocentryx CCXI:US $ 55.38M 0.65M
Clovis Oncology CLVS:US $ 173.88M 0.64M
Cti Biopharma CTIC:US $ 15.79M 0.23M
Eli Lilly And LLY:US $ 15093.2M 3379M
Exelixis EXEL:US $ 255.33M 41.99M
Gilead Sciences GILD:US $ 10214M 509M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Idera Pharmaceuticals IDRA:US $ 6.03M 1.03M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Macrogenics MGNX:US $ 69.92M 16.88M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Moderna Inc MRNA:US 8.84B 399M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Newlink Genetics NLNK:US $ 6.78M 1.79M
Novartis NOVN:VX SF 29633M 527M
Novartis NVS:US $ 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Puma Biotechnology PBYI:US $ 137.9M 2.51M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
YTE INCY:US $ 660.32M 36.44M